Connective Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Connective Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$3.26M	Buy	38,019 +16,377	+76%	+$1.47M	9.77%	3
2016 Q1	$1.88M	Buy	21,642 +5,343	+33%	+$478K	5.85%	5
2015 Q4	$1.84M	Buy	+16,299	New	+$1.77M	3.85%	7

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Societe Generale $14.1B AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Connective Capital Management's IBB Position: Q2 2016 in Review

Connective Capital Management increased its iShares Biotechnology ETF (IBB) stake by 76% in Q2 2016, buying an estimated $1.47M and bringing the position to 38,019 shares worth $3.26M. The position accounts for 9.77% of the portfolio, ranked #3.

Connective Capital Management first reported a position in IBB in Q4 2015 and has held it in 3 quarters since. 428 funds tracked by Wall St. Rank hold IBB as of Q2 2016.

Connective Capital Management held 38,019 shares of iShares Biotechnology ETF worth $3.26M as of Q2 2016.
Connective Capital Management bought 16,377 iShares Biotechnology ETF shares in Q2 2016, an estimated $1.47M.
iShares Biotechnology ETF made up 9.77% of Connective Capital Management's portfolio in Q2 2016, its #3 holding.
Connective Capital Management first reported a position in iShares Biotechnology ETF in Q4 2015 and has held it in 3 quarters since.
428 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2016.

Based on Connective Capital Management's 13F filing for Q2 2016, filed 9 Aug 2016.